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CHAPTER I

INTRODUCTION
The role of dopamine (3,4, dihydroxyphenethylamine) as an important
central neurotransmitter agent has been acknowledged for some time
(27).

It has only been in recent years, however, that the possibility

of a peripheral action of this catecholamine in the functional regulation of various organ systems has been given serious consideration,
and Goldberg (15) has proposed a specific role for this agent in the
control of the vascular dynamics of the kidney.

A number of electron

microscopic and fluorescent studies (2, 3, 28, 44) in this organ have
shown that there is a direct secretomotor innervation by the sympathetic nervous system of the juxtaglomerular cells of the afferent
arteriole.

These cells are involved in the synthesis and secretion

of the peptide hormone, renin.

Norepinephrine is the neurotransmitter

secreted by these sympathetic nerve terminals, and various studies
have indicated that this catecholamine may exert a direct stimulatory
control on renin secretion through a beta-adrenergic receptor mechanism, which utilizes cAMP as the intracellular mediator (8, 13, 31).
Some investigators (8, 23) have also recently postulated an inhibitory
role for norepinephrine on renin secretion, which appears to be mediated by alpha-adrenergic receptors.

The significance of the apparent

dual regulation of renin secretion by this catecholamine is unclear.
Despite the known importance of dopamine as a central nervous
system neurotransmitter, no attempts have been made to investigate the
possibility of renal dopaminergic nerve terminals participating in
the regulation of renin secretion, as well as to examine whether or
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not dopamine itself may be released from adrenergic nerve terminals
to exert its effect, since it is a direct precursor of norepinephrine.
Only two in vitro studies (18, 24) have addressed this question, and
the data suggests that dopamine may directly stimulate renin secretion
from rat renal cortical slices although the nature of the receptors
or mechanisms involved remain unclear.
In a review by Goldberg (15) a number of physiological actions
mediated by dopamine have been examined.

This investigator suggests

that the diversity of effects of this catecholamine on various organ
tissues may be explained on the basis of the structure of the moleculte itself, namely that the catecholamine head and flexible side
chain have the structural capability of binding to various types of
membrane receptors.

This would certainly support the view that dopa-

mine is capable of exerting a direct action on a given organ cell.
The data of Henry and co-workers (18) appear indicative of such a
direct influence of dopamine on the renal renin-secretory cells.
Furthermore, preliminary studies in our own lab (23) suggest not
only that dopamine directly stimulates renin secretion from the
juxtaglomeurlar cells, but that this effect may be mediated by intracellular cAMP changes.
Although the previously cited studies implicate dopamine itself
as having a direct effect on renin secretion, the possible conversion
of dopamine to norepinephrine in the tissue preparation constitutes
a factor which can not be overlooked.

The use of a dopamine beta-

hydroxylase inhibiting agent such as FLA-63 (5, 37) in in vitro
studies would eliminate this possibility.

A number of in vivo and in

vitro studies have shown FLA-63 to be an effective inhibitor of
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dopamine beta-hydroxylase at a range of concentrations in various
tissues (5, 7).
In order to eliminate in vivo humoral and hemodynamic influences
on renin secretion this investigation will utilize a hypersensitive
renal cortical slice preparation from rats maintained on a sodiumdeficient diet for 1.5 to 2.5 weeks.

Lopez and co-workers (23) have

confirmed previous in vivo work indicating that dietary sodium deficiency potentiates the renin secretory response to sympathetic stimuli.
The hypersensitive in vitro kidney slice preparation is an ideal
tool to more effectively evaluate not only positive, but as importantly
negative renin release responses to dopamine and various receptor
blockers, respectively.
Therefore, the purpose of the present study is: (1) to evaluate,
utilizing an in vitro rat renal cortical slice preparation, a possible direct stimulatory role of dopamine itself on the renin-secreting
juxtaglomerular cells of the kidney, when added either alone or in
conjunction with the specific dopamine receptor blocking agent, pimozide; (2) to examine the possibility that dopamine may partially exert
its influence on renin secretion through a beta-adrenergic receptor
mechanism, by the use of the beta-receptor blocker propranolol; and
(3) to elucidate whether or not cAMP is involved as an intracellular
mediator of the renin secretory response to added dopamine.

CHAPTER II
REVIEW OF LITERATURE
During the past ten years a number of important effects of
dopamine on peripheral organ tissue function have been proposed.
Dopamine has been shown to exert a number of effects in the cardiovascular system (17, 34, 35, 40), some of which appear to be mediated
by a beta-adrenergic receptor mechanism since the specific betaadrenergic blocking agent propranolol inhibits the stimulatory effect
of dopamine on heart rate and cardiac contractility.

As suggested

by Goldberg (15), these observations support the concept that dopamine
can effectively bind to membrane receptors other than specific dopamine-sensitive receptors.

This possibility is further supported by

examining the effects of dopamine on blood vessels.

Goldberg (17) and

others (26, 35) have shown that dopamine infusion can stimulate the
contractility of both arteries and veins.

These actions can be ef-

fectively blocked by high concentrations of phenoxybenzamine, an alphaadrenergic receptor blocker, which suggests that dopamine influences
vascular contractility through an alpha-adrenergic receptor mechanism.
Dopamine also appears to be involved in the relaxation and vasodilation of vascular tissue through reflex and neurogenic mechanisms.
This influence appears to be exerted by an action on beta-adrenergic
receptors.

In this regard, McNay and Goldberg (26) have demonstrated

that after phenoxybenzamine administration dopamine infusion causes
vasodilation in the skeletal muscle vascular bed of the dog.

Further-

more, Kohli (22) has shown that relaxation occurs in the isolated aortic
strip under similar conditions.

Propranolol antagonism of these
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actions suggests a dopamine-induced vasodilating mechanism exerted
through a beta-adrenergic receptor.

Conversely, propranolol antagon-

ism may not be due to beta-adrenergic receptor involvement but rather
to alpha vasoconstricting activity (32).

This view has been supported

by Goldberg and colleagues, who have shown that high concentrations of
propranolol do not alter dopamine-induced relaxation of isolated canine
renal, mesenteric, coronary or femoral arteries (39).
These conflicting observations have led to the postulation of
an alternative mechanism of action of dopamine on smooth muscle vasculature which involves a direct interaction with specific dopamine
vascular receptors (25).

In one such study, administration of phenoxy-

benzamine to an anesthesized dog, followed by an intra-arterial infusion of dopamine resulted in vasodilation of the renal and mesenteric
vascular beds in a dose-related fashion (17).

This vasodilating

effect could not be decreased by propranolol, atropine, anti-histamine
or by pretreatment with reserpine, 48/80, or monoamine oxidase
inhibitors (17).

Similar results have been observed by investigators

examining other vascular structures (34, 43).
The observations that dopamine causes renovascular dilation
through an apparent specific dopaminergic receptor has stimulated
the study of the role of this agent in blood pressure control and
renin secretion.

Most data in this regard have been obtained from

studies performed in vivo utilizing dogs or human subjects.

Ayers

and co-workers (1) have shown that dogs, made hypertensive by right
nephrectomy and partial occlusion of the left renal artery, exhibit
chronic elevation of blood pressure but renin secretion remained
normal.

They demonstrated that infusion of the vasodepressor drugs
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reserpine, hydralazine, and trimethophan did not produce significant
increases in renin release.

Conversely, infusion of isoproterenol

lowered the blood pressure and produced a marked stimulation of renin
release.

On the other hand, the same investigators observed a marked

increase in renin secretion following dopamine infusion in reno-vascular hypertension, in the presence of decreased, normal, or elevated
arterial blood pressures.

They concluded that it was not a blood

pressure change but rather vasodilation that was important in stimulating renin release.
A number of other investigators, working in vivo have also shown
that dopamine stimulates renin release.

In a series of experiments,

Bell and Lang (4) selectively initiated hemmorhage or acute suprarenal
aortic stenosis in mongrel dogs, and measured plasma angiotensin II
levels as an index of changes in renin secretion.

Under these condi-

tions, infusion of dopamine resulted in increased angiotensin II levels
in both the hemmorhaging and ischemic groups.

This increase was

effectively blocked by the dopamine receptor antagonist, ergometrine.
From these data, they concluded that stimulation of renin release is
exerted through dopaminergic nerves, although the mechanisms involved
are unclear.
Cuche and co-workers (11) have examined the involvement of dopamine
in regard to the effects of posture changes in humans.

It has already

been established that changing from the supine to upright posture in
humans stimulates the sympathetic

nervous system (21).

In their

studies, they found that upon changing from the supine to the upright
position, plasma renin activity increased, urinary dopamine concentration decreased, urinary norepinephrine concentration increased, and
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urinary sodium concentration decreased.

From these data Cuche and

his group proposed a number of possible effects of dopamine on renin
secretion.

Since dopamine possesses some alpha-adrenergic action but

little or no beta-adrenergic activity its inhibitory effect on renin
release may be mediated by either a specific dopaminergic receptor
or alternatively by competing with norepinephrine at the receptors of
the juxtaglomerular cells.

Therefore, each catecholamine could con-

ceivably have an affect on renin-secretion through a direct action on
the renin secreting cells.

Cuche and co-workers (11) have alternative-

ly suggested that dopamine may affect renin secretion through its
effect on sodium excretion.

This appears to be an indirect inhibitory

effect on renin release through increases in sodium load at the
macula densa.

Furthermore, they have indicated that dopamine action

could also be mediated by renal blood flow-dependent pressure changes
at the juxtaglomerular cells, since dopamine inhibits plasma renin
activity under conditions of low renal plasma flow (11).

This action

may be mediated by the afferent arteriole baroreceptors.

Wilcox and

his group (46) have also compared the effects of dopamine and norepinephrine on renin release in human subjects.

They observed that

plasma renin activity was increased with dopamine infusion.

Plasma

renin activity decreased with equipressor doses of norepinephrine.
These data, although in disagreement with previous data suggesting an
inhibitory role of dopamine on renin release, may actually support the
view that it is the activation of specific dopaminergic receptors which
mediate the effect of dopamine on renin

secret~on.

Additional studies by Chokshi and colleagues (9), have done little

/

8

to further clarify whether or not dopamine is directly stimulatory or
inhibitory to renin secretion.

In these studies dopamine and isopro-

terenol were alternately infused into the renal artery of adult dogs.
Under these conditions, it was found that dopamine increased renal
blood flow and decreased renin secretion, while isoproterenol increased
both parameters.

Propranolol treatment prior to dopamine infusion

did not alter the response in renal blood flow or renin secretion.
Infusion of propranolol prior to isoproterenol blocked the increase
in renin secretion with no change in renal blood flow.

The results

seen with dopamine in these studies can be explained by the known
vasodilating properties of dopamine on the renal vasculature which
would cause a decrease in renin release.

This would be considered an

indirect effect rather than a direct one on the juxtaglomerular cells.
Most in vivo studies evaluating the possibility of a direct effeet of dopamine on renin release have produced inconclusive data,
perhaps because of the variety of factors interrelating in the live
animal to influence secretion of this hormone.

The possible mechanism

and site of action of dopamine have therefore, remained largely unclear.

Recently, however, a few in vitro studies have been more pro-

mising in this regard,

primarily because this type of preparation

effectively eliminates humoral, hemodynamic and other in vivo influences
which are known to affect renin release.
Nakajimaand colleagues (29) have shown that addition of dopamine
to an in vitro rat kidney particulate preparation produced significant
increases in the cAMP content of the tissue.

This increase in the
/

tissue nucleotide concentration was not affected by simultaneous addition of either the adrenergic blocker, phentolamine, or the beta-
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adrenergic blocker, propranolol.

This suggests the involvement of

an alternative type of receptor.

Addition of spiroperidol, a speci-

fic dopamine-receptor antagonist, effectively blocked the increase in
tissue cAMP by dopamine, whereas, apomorphine, an analog of dopamine,
increased tissue cAMP content when added to the preparation.

From

these observations, Nakajima and co-workers concluded that the increase
in cAMP produced by the addition of dopamine constitutes evidence
for the existence of a cAMP mediated dopamine-receptor mechanism in
renal vascular tissue.

This view is consistent with the existence

of a dopamine-sensitive adenylate cyclase mechanism in the mammalian
brain and retina (6, 10, 20).
In a follow-up study, Nakajima and co-workers (30) perfused an
isolated rat kidney with various reagents.

Perfusion with dopamine

resulted in a significant increase in cAMP concentration in the perfusate.

The increase in the concentration of this nucleotide was

potentiated by theophylline, a phosphodiesterase inhibitor, and consistently blocked by spiroperidol, a dopamine-receptor blocking agent.
They also observed that the stimulatory effect of dopamine on cAMP
concentration was very rapid, an observation which is consistent
with the proposed mechanism of action of receptors which utilize cAMP
as an intracellular mediator.

Nakajima and colleagues (29) have

suggested that dopamine acts through a specific dopamine receptor
located on the vascular tissue of the rat kidney to produce vasodilation.

This view agrees with the concept of a renal vascular receptor

proposed by Yeh, McNay and Goldberg (42).
In contrast, Henry and co-workers (18) utilizing an in vitro rat
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renal cortical slice preparation, have recently evaluated the possibility of a direct effect of dopamine on renin secretion.

Addition of

dopamine at concentrations greater than 10-5 M resulted in significant
increases in renin release, an observation which suggests a direct
effect of this amine on the juxtaglomerular cells.

Moreover, pheni-

prazine, a monoamine oxidase inhibitor, potentiated the rate of renin
release.

In the same studies, simultaneous addition of phentolamine

(an alpha--adrenergic receptor blocker), haloperidol (a dopamine-receptor blocker), or cocaine (a catecholamine uptake inhibitor) did not
affect the stimulatory effect of dopamine on renin release.

However,

the addition of propranolol, a beta-adrenergic receptor blocker, significantly inhbited the stimulatory effect of dopamine on renin secretion.
From these observations, Henry and colleagues concluded that dopamine
may directly influence renin release from the juxtaglomerular cells
via a beta-adrenergic

receptor mechanism most likely located on the

membranes of those cells, rather than by a dopamine-sensitive receptor
pathway.
Recent studies in our laboratory (24) have supported Henry's observation of a direct stimulatory effect of dopamine on renin secretion.

We further extended their findings by clearly showing a positive

correlation between the renin secretory responses and the changes in
tissue cAMP content.

This constitutes additional evidence for the

existence of a cAMP·-mediated receptor mechanism by which dopamine
may directly influence renin release.

Additionally, it has been

shown (24) that pimozide, a dopamine receptor blocking agent, effectively prevents the stimulatory effect of dopamine on renin release.
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This observation is not in agreement with Henry's, but supports the
concept of a dopamine-sensitive receptor mechanism mediating the
stimulation of renin secretion by dopamine.
It is obvious from the data reviewed here, that additional
studies are needed to further examine the possibility that this important central nervous system neurotransmitter may play a significant
regulatory role in the control of renin secretion, and thus, may
participate in the regulation of extracellular fluid volume, electrolyte, and blood pressure homeostasis.

CHAPTER III
MATERIALS AND METHODS
Thirty-six male, Sprague-Dawley rats (Madison, Wisconsin), with
initial weights of 210 ± 10 gm were fed a sodium-deficient diet, (Teklad
Test Diets, Madison, Wisconsin), which provided less than 0.02
sodium per day, for a period of 10 to 17 days.

~g

of

The rats were kept two

animals per cage, in a temperature-controlled room (23 ± 20 C) with a
12 hour light/12 hour dark photoperiod.
tilled, deionized water ad libitum.

The rats had access to dis-

After 10 to 17 days on the diet,

the animals were decapitated and their kidneys rapidly excised.

The

kidneys were then placed in Robinson's buffer medium at 4° C (12),
gassed for 30 seconds with a mixture of 95% oxygen - 5% carbon dioxide,
decapsulated, and gassed a second time.

Renal cortical slices approxi-

mately 0.3 mrn thick and weighing 50 ± 20 mg were subsequently prepared
using a Stadie-Rigg's microtome (A.H. Thomas, Co.).
Each slice was divided into several similar sections, which were
randomly assigned to seven incubating vessels containing 2.5 ml Robinson's
buffer medium at 4° C.

Renal slices from other areas of the cortex

were similarly prepared until each incubating vessel contained 50 ±
20 mg of renal cortical tissue.

The slices were then preincubated

for 15 minutes at 37° C in a shaking Dubnoff Metabolic Incubator
(Precision Scientific Cn), in a humidified atmosphere of 95% oxygen
5% carbon dioxide.

After preincubation, the slices were transferred

to matching vessels containing fresh Robinson's buffer medium at 37° C
and were subsequently incubated for one hour under conditions identical

12
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To those during preincubation.

One of each group of seven paired

vessels served as an untreated control.

The other six vessels con-

taining the tissue slices received 10- 3 M dopamine (Sigma Chemical
Co.) added alone or in conjunction with lo-4 M of the beta-receptor
blocking agent, propranolol (Sigma Chemical Co.), or one of three
doses (10-? M, 10-6M, 10- 5 M), of the dopaminergic receptor blocking
agent, pimozide (Janssen Pharmaceutical).

Propranolol and pimozide

were also added alone to the slice preparation.

The dopamine beta-

hydroxylase inhibitor, FLA-63 (10- 4 M) (Regis Chemical Co.) was added
in conjunction with the experimental agents in all instances in order
to inhibit the conversion of dopamine to norepinephrine.

Control tis-

sue was incubated in the presence or absence of FLA-63.

The antagonis-

tic agents and FLA-63 were added to the slice preparation in both the
preincubation and incubation periods, whereas dopamine was added only
in the incubation media.

Dopamine and FLA-63 were prepared in a

0.1% ascorbic acid solution (Sigma Chemical Co.) to prevent oxidation
(45).

Pimozide was prepared in 1.2% tartaric acid (Fisher), also to

prevent oxidation.
medium.

Propranolol was dissolved in Robinson's buffer

After incubation, the supernatant medium was collected and

stored at -20° C until assayed for renin concentration by radioimmunoassay of angiotensin I.

The renal tjssue was immediately frozen on

dry-ice and homogenized in l ml of 8% trichloracetic acid (Mallinkrodt).
The tissue homogenates were transferred to 12 x 75 mm pyrex tubes
(Scientific Products), containing five drops of 0.1 N HCl, vortexed,
and frozen at -200 C until assayed for cAHP content.
A.

Renin Concentration Determination by Radioimmunoassay Angiotensin I
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1.

Angiotensin I Generation
Since no direct assay exists for renin, renin concentration was

measured by determining the rate of Angiotensin I formation in the presence of exogenous renin substrate (angiotensinogen).

'

This was follow-

ed by radioimmunoassay measurement of the Angiotensin I generated,
which is proportional to the amount of renin present.

To generate

Angiotensin I, the supernatant samples were thawed, vortexed for ten
seconds and maintained in a water bath at 40 C.

Aliquots of 25

~1

from each sample were transferred to 12 x 75 mm tubes and kept at 4°
C.

Five drops of saturated NaCl, and 0.5 ml of 24-hour nephrectomized

dog plasma, containing renin substrate (angiotensinogen) were then
added to each tube.

The nephrectomized plasma had previously been

treated with a 1% phenylmethylsulfonylflouride (PMSF) solution (0.05 ml
of PMSF/ml of plasma) to inhibit the action of converting enzyme and
other angiotensinases present in plasma.

Thus, the degradation of

generated Angiotensin I or the conversion of Angiotensin I to Angiotensin II was prevented.

The PMSF treated nephrectomized dog plasma

was then incubated for two hours at 37° C, followed by a 1:2 dilution
with distilled, deionized water.

The samples were then vortexed,

covered with aluminum foil to prevent evaporation, and placed in a
boiling water bath for 2-3 minutes to stop further Angiotensin I generation.

The samples were allowed to cool to room temperature, covered

with parafilm, and stored at -20° C until assayed for Angiotensin I
content by radioimmunoassay.
2.

Radioimmunoassay of Angiotensin I
Renin concentration in the unknown samples was determined by
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radioimmunoassay of the generated Angiotensin I, utilizing as trace,
radioiodinated Angiotensin I (125I-Angiotensin I) and buffer solutions
from the Squibb Company (Rolling Meadows, IL) and an Angiotensin I
antibody (38) generously donated by Dr. Ian Reid (University of
California at San Francisco).

The results were expressed as nanograms

of Angiotensin I generated per mg of wet tissue per hour.
B.

Determination of Cyclic 3'-5' Adenosine Monophosphate (cAMP) by
Competitive Protein Binding Assay

1.

cAMP Extraction
Frozen tissue homogenates were allowed to thaw and then centrifuged

at 4000 rpm for ten minutes at 4° C.

The supernatant was transferred

to conical centrifuge tubes using Pasteur pipets (Sargent-Welch) and
the protein precipitate discarded.

Two ml of water-saturated ether

(Mallinkrodt) were then added to each sample, vortexed, and the ether
phase was aspirated and discarded using Pasteur pipets.
was repeated three times.

This procedure

After the fourth wash, the cAMP-containing

water phase was decanted into glass vials and immediately frozen on
dry-ice.

The frozen samples containing the water-soluble cAMP were

subsequntly lyophilized and the freeze-dried cAMP was then stored.at
-200 C until assayed.
2.

Competitive Protein Binding Assay for cAMP
Cyclic AMP content of the tissue slices was determined by a

modification of the protein-binding assay of Gilman (14).
were expressed as picomoles of cAMP per mg of wet tissue.

The results
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C.

Calculations
Statistical significance of the various parameters studied was

evaluated by modified paired and unpaired students "t" tests (36)
using a programmable desk top calculator (Hewlett-Packard 9100B) at
Argonne National Laboratory (Argonne, IL).

CHAPTER IV

RESULTS
In an initial study the effect of the dopamine-beta-hydroxylase
inhibitor, FLA-63 (lo- 4 M) on the basal renin release and cAMP content
of rat renal cortical slices from sodium-deficient rats was examined.
There were no significant differences in either renin release or cAMP
content between non-treated {control) or FLA-63 treated tissue.

The

mean change in renin release from control for tissue treated with
FLA-63 was -0.023 ± 0. 25 ng/mg wet tissue/hour (P > 0. 05).

The mean

changes in cAMP content from control was 0.0009 ± 0.009 pmole/mg wet
tissue (P > 0. 05).

Thus, FLA-63 was utilized in conjunction with

other experimental agents in subsequent studies.
Figure 1 shows the renin release and tissue cAMP content changes
seen in renal cortical slices treated with 10-3 M dopamine alone or
10-3 M dopamine added together with FLA-63.

In both instances, dopa-

mine signficantly increased both renin release and the cAMP content
of the tissue during a one hour incubation period.
In another study the effect of a stimulatory dopamine dose (lo-3 M)
on renin release was evaluated when the specific dopamine-receptor
blocking agent, pimozide (10-6M), was added to the slice preparation
in the presence or absence of FLA-63 (lo-4 M).
seen in Figure 2.

These data can be

In the absence of FLA-63, pimozide blocked the

stimulatory effect of lo- 3 M dopamine on renin release in rat renal
cortical slices from sodium-deficient rats.

Pimozide added by itself

also significantly inhibited renin release.

In contrast, when pimozide
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was added together with dopamine in the presence of FLA-63, it potentiated the stimulatory effect of dopamine on renin release, an effect
which was completely opposite to the inhibition on this parameter
exerted by pimozide, when FLA-63 was absent from the preparation.
Furthermore, when pimozide alone was added to the slice preparation
in the presence of FLA-63, renin secretion was significantly stimulated
in relation to control.
When the data on renin release (Figure 2) are compared to those
in cAMP content in response to the same doses of dopamine and pimozide,
in the presence of added FLA-63 (Figure 3), a clear dissociation
between renin release responses and cAMP content changes was apparent.
Previously it had been observed that without FLA-63 in the incubation
medium, pimozide added together with dopamine significantly decreased
both renin release and tissue cAMP content below control levels.

The

inhibitory effect of pimozide on tissue cA}W content was maintained
when FLA-63 was added to the tissue preparation (Figure 3), whereas
it was significantly reversed in regard to renin release (Figure 2).
Moreover, the tissue cAMP content was significantly depressed in
response to pimozide added alone (Figure 3) whether or not FLA-63
was present.
Since pimozide added alone to the renal cortical preparation
significantly influenced both renin release and tissue cAMP, further
experiments were undertaken to find a pimozide dose which by itself
would be ineffective in influencing these parameters.

Various doses

of pimozide (lo-7 M, lo-6 M, 10-5 M) were added to the slice preparation either alone or in conjunction with a stimulatory dopamine dose
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FLA-63 (10-4M) was present in all instances.

As seen

previously with lo- 6 M pimozide (Figure 3), additional doses of this
agent in the presence of FLA-63 significantly potentiated the stimulatory effect of 10- 3 M dopamine on renin secretion (Figure 4).

The

three pimozide doses added by themselves were also capable of significantly stimulating renin release.

The stimulatory effect of each dose

was not statistically different from the other two, an observation
which suggests maximal potentiation at this range of pimozide
concentrations.
At the three concentrations used, pimozide significantly decreased
cAMP content of the tissue preparation when added either alone or
in conjunction with dopamine.

These data on cAMP content are again

similar to those observed in previous studies in the absence of FLA-63.
Also as previously observed with lo-6 M pimozide in the presence of
FLA-63, the additional pimozide doses, either alone or together with
dopamine, produced a marked dissociation of the renin release and
tissue cAMP responses.

Furthermore, the inhibitory effect of all

three pimozide doses on tissue cAMP content when added alone appeared
maximal.
Since dopamine may structurally be capable of binding to other
types of receptors, an additional study was performed to explore
this possibility.

In these experiments (Figure 6), a stimulatory

dose of dopamine (lo- 3 M) was added alone or together with the betaadrenergic receptor blocker propranolol (10- 4 M) to renal cortical
slices from sodium-deficient rats.

FLA-63 (lo-4 M) was also added in

conjunction with all treatments. At the concentration used, propranolol
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effectively prevented the stimulatory effect of dopamine on renin
secretion.

Propranolol added by itself was ineffective.

Similarly,

propranolol effectively blocked the stimulatory effect of dopamine
on tissue cAMP content seen previously.

By itself, however, propranolol

was also capable of inhibiting tissue cAMP content.
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CHAPTER V

DISCUSSION

The in vivo studies of Goldberg and colleagues (16, 26, 47)
and the in vitro observations of Nakajima and co-workers (29, 30)
have provided strong evidence pointing to the existence of specific
dopaminergic receptors involved in the control of renal vascular
dynamics.

The postulated receptors appear to be located on the walls

of the renal blood vessels.

These vascular receptors may well exist,

however, their existence does not rule out the possibility that
a specific dopamine receptor may be located elsewhere in the kidney,
subserving other functions, and perhaps renin secretion.

Data from

in vitro studies of Henry and his group (18) support the view that
renal dopamine receptors may be located on the renin-secreting juxtaglomerular cells.

They propose that the stimulatory effect of dopa-

mine is mediated by a beta-adrenergic receptor mechanism, similar to
that involved in mediating the action of other catecholamines, such
as norepinephrine.

Additional observations by Lopez and co-workers

(23) support the concept that the effect of dopamine on renin secretion may be directly exerted through a specific dopamine receptor
located on the juxtaglomerular cells and that this receptor mechanism
may be intracellularly mediated by cAMP changes.
The present study further attempts to evaluate the possibility
of a direct regulation of renin release by dopamine.

FLA-63 (lo-4 M)

by itself had no significant effect on resting renin release or
cAMP content of the tissue.

This is important since it essentially
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eliminates the possibility that the added FLA-63 affects either renin
release or tissue cAMP content.

Furthermore, in the presence of FLA-

63, dopamine (10-3 M) stimulates renin release and cAMP content
simultaneously (Figure 1).

Values for renin secretion and cAMP con-

tent were not statistically different from preparations in which dopamine was added without FLA-63.

These data suggest that a dopamine-

sensitive membrane receptor exists and that the stimulatory effect of
dopamine on renin release may be mediated by increasing tissue

c&~

content.
In the presence of FLA-63, pimozide markedly potentiated the dopamine stimulatory effect on release (Figure 2).

This is in direct con-

trast to previous observations (23) that pimzoide blocked the stimulatory effect of dopamine on renin secretion when FLA-63 was absent
from the incubation media.

Pimzoide added alone to the slice prepar-

ation in the presence of FLA-63 also significantly increased renin
release as opposed to its inhibitory effects when FLA-63 was not present (23).

Conversely, pimozide added either alone or in conjunction

with a stimulatory dose of dopamine significantly inhibited tissue
cAMP generation in relation to controls whether FLA-63 was present
or not (Figure 3).

This dissociation of the effects of pimozide on

renin release and cAMP content of the tissue when FLA-63 is added to
the preparation is not easily explained.

One possible explanation is

that dopamine, itself, may actually control renin secretion in an
inhibitory manner through a specific dopamine receptor mechanism and
that the addition of pimozide releases this inhibition.

However, the

simultaneous significant decrease in tissue cA}W by pimozide is not
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consistent with this view.

Alternatively, since pimozide by itself

was capable of causing marked increases in renin release and decreases
in tissue cAMP content it is possible that the observed responses are
strictly due to a generalized membrane effect of this agent.

The

effect being uncontrolled renin release from the juxtaglomerular
cells, despite inhibition of secretory mechanisms mediated by cAMP.
This generalized membrane effect concept has previously been postulated by Johns and co-workers (19) to explain the stimulatory influence
of the synthetic catecholamine, isoproterenol, on renin secretion.
It is also possible that pimozide and FLA-63 may interact in some
manner to initiate these responses although the mechanism is unclear.
Subsequent studies utilizing additional doses of pimozide, in
the presence of FLA-63, largely confirmed the initial observations
that pimozide added alone or together with dopamine, is capable of
significantly potentiating renin release.

At the three doses

examined,

pimozide appeared to exert maximal effects on both renin release and
cAMP content since no significant differences were detected when the
various responses were statistically compared.
It is obvious from these data, that the question regarding the
involvement of a dopamine-sensitive receptor in mediating the effect
of dopamine on renin release can not be properly evaluated.

It is

necessary to find a dose of pimozide which, by itself, is ineffective
in influencing both renin release and tissue cAMP content, as well as
to examine other specific dopamine receptor blocking agents such as
butaclamol.

These data should be of great value in determine whether

or not dopamine directly affects renin secretion through a specific
dopamine-receptor pathway.

36

The observations of this study indicate that dopamine, by
itself, is capable of significantly and simulatenously stimulating
both renin release and tissue cAMP content, while the report of
Henry and co-workers (18) suggests that this stimulatory effect may be
mediated by a beta-adrenergic mechanism.

To investigate the possibility

that the renin-secretory responses to dopamine may be mediated by a
beta-adrenergic mechanism a subsequent experiment utilized the specific beta-adrenergic receptor blocker, propranolol.

In the presence

of FLA-63 (10- 4 M), propranolol (lo-4 M) effectively prevented the
stimulatory effect of dopamine (lo- 3 M) on renin secretion and cAMP
content.

Propranolol by itself had no effect on renin secretion, but

it did inhibit tissue cAMP content.

These data are consistent with

the concept that the stimulatory effects of dopamine on renin secretion may be at least partially mediated by a beta-adrenergic receptor
mechanism.

Goldberg (15) has reported that dopamine is capable of

binding to receptors other than specific dopamine ones, due to its
catechloamine head and flexible side chain.

Additional studies are

being designed to examine the possiblity of a partial dopaminergic
regulation of renin secretion through renal alpha-adrenergic receptors different from those known to mediate blood pressure changes
in the renal vasculature.
In summary, the data present here support the view that dopamine
itself exerts a direct regulation of renin secretion from the juxtaglomerular cells of the sodium-deficient rat.

These results also sup-

port the view that this control of renin release by dopamine is partially
exerted through a beta-adrenergic receptor mechanism which utilizes
cAMP as the intracellular mediator.
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However, the data have left unanswered the question as to
whether or not the regulatory influence of dopamine on renin release
is mediated by a specific dopamine-sensitive receptor mechanism.
Studies designed to further evaluate this possibility, as well as
the possibility that dopamine may partially regulate renin release
through other receptor types, are clearly needed.
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